Evidence map›Paper›PMID 10860209›Full record

ArticleJournal of medical ethics2000

Can unequal be more fair? A response to Andrew Avins.

S J Edwards, D A Braunholtz

Abstract readComment
In one paragraph

Article in Journal of medical ethics, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Does nirsevimab prevent lower respiratory infections caused by respiratory syncytial virus?Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

S J EdwardsDepartment of Primary Care and General Practice, University of Birmingham.
D A Braunholtz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we respond to Andrew Avins's recent review of methods whose use he advocates in clinical trials, to make them more ethical. He recommends in particular, "unbalanced randomisation". However, we argue that, before such a recommendation can be made, it is important to establish why unequal randomisation might offer ethical advantages over equal randomisation, other things being equal. It is important to make a pragmatic distinction between trials of treatments that are already routinely available and trials of restricted treatments. We conclude that unequal randomisation could, indeed, be an ethical compromise between protecting the interests of participants and those of society.

Indexed as

Ethics, MedicalEnglandEthical AnalysisEthicsEthics, ResearchHumansPatient AdvocacyPatient SelectionRandomized Controlled Trials as TopicResearch DesignResearch SubjectsSocial JusticeTherapeutic Human ExperimentationBiomedical and Behavioral Research

Identifiers

PMID10860209
PMCPMC1733212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.